Cargando…

Time to treatment initiation and its impact on real‐world survival in metastatic colorectal cancer and pancreatic cancer

BACKGROUND: Given the dearth of data regarding the time to treatment initiation (TTI) in the palliative setting, and its impact on survival outcomes, we sought to determine TTI in a real‐world cohort of metastatic colorectal cancer (mCRC) and metastatic pancreatic cancer (mPC) patients and evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gbolahan, Olumide, Hashemi‐Sadraei, Neda, Yash, Suri, Williams, Grant, Ramachandran, Rekha, Kim, Young‐il, Paluri, Ravikumar, Outlaw, Darryl, El‐Rayes, Bassel, Nabell, Lisle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939095/ https://www.ncbi.nlm.nih.gov/pubmed/35979540 http://dx.doi.org/10.1002/cam4.5133

Ejemplares similares

Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018
por: Nghiem, Van, et al.
Publicado: (2023)

Geographical and Racial Disparities in Head and Neck Cancer Diagnosis in South-Eastern United States: Using Real-World Electronic Medical Records Data
por: Mukherjee, Amrita, et al.
Publicado: (2020)

Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control
por: Sharma, Harsh, et al.
Publicado: (2023)

Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis
por: Paluri, Ravi Kumar, et al.
Publicado: (2023)

Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies–Results from the CARE registry
por: Clausing, Daniel, et al.
Publicado: (2023)

Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients
por: Mukherjee, Amrita, et al.
Publicado: (2023)

Identifying and targeting cancer stem cells in the treatment of gastric cancer
por: Bekaii‐Saab, Tanios, et al.
Publicado: (2017)

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer
por: Stringer-Reasor, Erica M., et al.
Publicado: (2021)

Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer
por: Giri, Smith, et al.
Publicado: (2022)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies
por: Wagner, Marcus M, et al.
Publicado: (2012)

Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study
por: Prieto, Veronica, et al.
Publicado: (2017)

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
por: Kang, Sandra, et al.
Publicado: (2022)

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study
por: Gbolahan, Olumide B., et al.
Publicado: (2019)

Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges
por: Rahmathulla, Gazanfar, et al.
Publicado: (2013)

Bilateral Acromioclavicular Septic Arthritis as an Initial Presentation of Streptococcus pneumoniae Endocarditis
por: Hashemi-Sadraei, Neda, et al.
Publicado: (2014)

Extramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase Inhibitors
por: Soni, Abha, et al.
Publicado: (2016)

Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis: Hematologic Emergency in the Critical Care Setting
por: Hashemi-Sadraei, Neda, et al.
Publicado: (2015)

Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer
por: Ware, Michael Brandon, et al.
Publicado: (2020)

Adjuvant therapy for pancreas cancer in an era of value based cancer care
por: Ahn, Daniel H., et al.
Publicado: (2015)

Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study
por: Atallah, Rami P., et al.
Publicado: (2022)

Metastatic Adenocarcinoma of the Bladder Presenting as Malignant Pleural Effusion: A Rare Presentation of Bladder Adenocarcinoma
por: Ravikumar, Rekha, et al.
Publicado: (2021)

The Potential of CAR T Cell Therapy in Pancreatic Cancer
por: Akce, Mehmet, et al.
Publicado: (2018)

Metastatic Alveolar Rhabdomyosarcoma with Extensive Bone Marrow Replacement in an Older Adult
por: Cheng, Justin J., et al.
Publicado: (2021)

Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer
por: Akce, Mehmet, et al.
Publicado: (2023)

Advances in pancreatic cancer biomarkers
por: Hasan, Syed, et al.
Publicado: (2019)

An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer
por: Patil, Pradnya Dinkar, et al.
Publicado: (2019)

Metastatic Gastric Cancer to the Colon
por: Then, Eric Omar, et al.
Publicado: (2021)

Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot Study
por: Kim, Harrison, et al.
Publicado: (2019)

Proteomic Markers for Mechanobiological Properties of Metastatic Cancer Cells
por: Leonov, Sergey, et al.
Publicado: (2023)

Use of Pro in Evaluating TAA and its Indications
por: Suri, Yash
Publicado: (2022)

HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
por: Nagaraju, Ganji Purnachandra, et al.
Publicado: (2014)

Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States
por: Paluri, Ravi, et al.
Publicado: (2022)

Budget Impact Analysis of Ixabepilone Used According to FDA Approved Labeling in Treatment-Resistant Metastatic Breast Cancer
por: Ho, Joanne, et al.
Publicado: (2009)

Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer
por: Liu, Shuai, et al.
Publicado: (2022)

Open pipelines for integrated tumor genome profiles reveal differences between pancreatic cancer tumors and cell lines
por: Goecks, Jeremy, et al.
Publicado: (2015)

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
por: Sahin, Ibrahim Halil, et al.
Publicado: (2019)

Frontline therapy for advanced hepatocellular carcinoma: an update
por: Akce, Mehmet, et al.
Publicado: (2022)

Eligibility of real-world patients with metastatic breast cancer for clinical trials
por: Batra, Atul, et al.
Publicado: (2020)

The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer
por: Song, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njavcmk4u8nugbdnirlrcnack9